The class of ROS inhibitors encompasses a variety of chemicals with distinct mechanisms targeting different sources of reactive oxygen species (ROS) within the cell. DPI (Diphenyleneiodonium chloride), for instance, acts as an indirect inhibitor by targeting flavoproteins, including NADPH oxidases, key contributors to cellular ROS production. By inhibiting NADPH oxidase activity, DPI disrupts the enzymatic generation of ROS, providing an indirect method of inhibiting ROS production within the cell. Apocynin, on the other hand, serves as a direct ROS inhibitor by specifically inhibiting NADPH oxidase activity. This direct inhibition stops one of the major sources of cellular ROS, highlighting Apocynin's potential as a direct ROS inhibitor. MitoTEMPO, a mitochondria-targeted antioxidant, directly inhibits mitochondrial ROS production by scavenging ROS within the mitochondria. Its action on mitochondrial ROS provides a direct avenue for inhibiting ROS generation within this organelle.
Rotenone and 3-Nitropropionic acid showcase indirect inhibition of ROS production by targeting complex I and complex II of the mitochondrial electron transport chain, respectively. VAS2870 and Xanthohumol act as direct ROS inhibitors by specifically inhibiting NADPH oxidase activity, stopping the enzymatic generation of ROS. Their action on NADPH oxidase serves as a direct avenue for inhibiting ROS production within the cell. Ebselen, a scavenger of peroxynitrite, reduces oxidative stress, providing an indirect method of inhibiting ROS generation. Its action on peroxynitrite highlights Ebselen's potential as an indirect inhibitor of ROS production within the cellular environment. Dimethyl fumarate (DMF) operates through an indirect mechanism by activating the Nrf2-antioxidant response element (ARE) pathway, promoting the expression of antioxidant enzymes. Allopurinol, N-acetylcysteine (NAC), and Caffeic acid phenethyl ester (CAPE) directly inhibit ROS production by targeting xanthine oxidase, replenishing cellular glutathione levels, and inhibiting NADPH oxidase activity, respectively.